Phil Skolnick - Net Worth and Insider Trading
Phil Skolnick Net Worth
The estimated net worth of Phil Skolnick is at least $444,966 dollars as of 2024-05-24. Phil Skolnick is the Chief Scientific Officer of Opiant Pharmaceuticals Inc and owns about 21,548 shares of Opiant Pharmaceuticals Inc (OPNT) stock worth over $444,966. Details can be seen in Phil Skolnick's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Phil Skolnick has not made any transactions after 2023-01-27 and currently still holds the listed stock(s).
Transaction Summary of Phil Skolnick
Phil Skolnick Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Phil Skolnick owns 1 companies in total, including Opiant Pharmaceuticals Inc (OPNT) .
Click here to see the complete history of Phil Skolnick’s form 4 insider trades.
Insider Ownership Summary of Phil Skolnick
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OPNT | Opiant Pharmaceuticals Inc | 2023-01-27 | Chief Scientific Officer |
Phil Skolnick Latest Holdings Summary
Phil Skolnick currently owns a total of 1 stock. Phil Skolnick owns 21,548 shares of Opiant Pharmaceuticals Inc (OPNT) as of January 27, 2023, with a value of $444,966.
Latest Holdings of Phil Skolnick
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OPNT | Opiant Pharmaceuticals Inc | 2023-01-27 | 21,548 | 20.65 | 444,966 |
Holding Weightings of Phil Skolnick
Phil Skolnick Form 4 Trading Tracker
According to the SEC Form 4 filings, Phil Skolnick has made a total of 16 transactions in Opiant Pharmaceuticals Inc (OPNT) over the past 5 years, including 0 buys and 16 sells. The most-recent trade in Opiant Pharmaceuticals Inc is the sale of 480 shares on January 27, 2023, which brought Phil Skolnick around $9,725.
Insider Trading History of Phil Skolnick
- 1
Phil Skolnick Trading Performance
Phil Skolnick Ownership Network
Phil Skolnick Owned Company Details
What does Opiant Pharmaceuticals Inc do?
Who are the key executives at Opiant Pharmaceuticals Inc?
Phil Skolnick is the Chief Scientific Officer of Opiant Pharmaceuticals Inc. Other key executives at Opiant Pharmaceuticals Inc include other: General Counsel Brian Gorman , director & 10 percent owner & Chief Executive Officer Roger Crystal , and other: UK Managing Director Ellison Mark Jason Heath .
Opiant Pharmaceuticals Inc (OPNT) Insider Trades Summary
Over the past 18 months, Phil Skolnick made 3 insider transaction in Opiant Pharmaceuticals Inc (OPNT) with a net sale of 2,270. Other recent insider transactions involving Opiant Pharmaceuticals Inc (OPNT) include a net sale of 7,570 shares made by Roger Crystal , a net sale of 2,885 shares made by Ellison Mark Jason Heath , and a net sale of 2,556 shares made by David D O'toole .
In summary, during the past 3 months, insiders sold 0 shares of Opiant Pharmaceuticals Inc (OPNT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 17,038 shares of Opiant Pharmaceuticals Inc (OPNT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 17,038 shares.
Opiant Pharmaceuticals Inc (OPNT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Opiant Pharmaceuticals Inc Insider Transactions
Phil Skolnick Mailing Address
Above is the net worth, insider trading, and ownership report for Phil Skolnick. You might contact Phil Skolnick via mailing address: C/o Dov Pharmaceutical, Inc., 433 Hackensack Avenue, Hackensack Nj 07601.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
